RUNX3 and leukemia: RUNX3 mRNA expression was also examined in various cancer cell lines including colon cancer (RKO and HCT116), gastric cancer (MKN-1 and MKN-45), leukemia (HL60), lymphoma (U937) and breast cancer (MCF7 and SK-BR3) (Figure 1C).